Table 5.
Use of Prescription Medications and OTC Products by Those With Diagnosed, Current Plantar Fasciitis Pain
| Prevalence in Those With Diagnosed Plantar Fasciitis* (N = 650)
|
||
|---|---|---|
| Drug Used for Any Type of Painn (Weighted Column %, 95% CI) |
Drug Used Specifically for Plantar Fasciitis Painn (Weighted Column %, 95% CI) |
|
| Any prescription drug | 261 (41.04, 36.78–45.3) | 38 (6.31, 4.21–8.42) |
| Opioid use | 172 (27.97, 23.93–32.0) | 14 (2.21, .93–3.48) |
| Prescription NSAIDs | 138 (23.73, 19.77–27.69) | 23 (4.01, 2.3–5.72) |
| Anticonvulsants | 55 (7.88, 5.75–10.01) | 0 |
| SNRI | 15 (1.94, .95–2.94) | 0 |
| Muscle relaxants | 62 (9.94, 7.51–12.48) | 0 |
| Amitriptyline | 9 (1.47, .49–2.46) | 0 |
| Any OTC | 466 (69.88, 65.77–73.98) | Data not collected |
| Any OTC analgesic | 441 (66.39, 62.22–70.56) | Data not collected |
| OTC acetaminophen | 175 (26.93, 23.19–30.67) | Data not collected |
| OTC NSAIDs | 329 (49.48, 45.23–53.73) | Data not collected |
| OTC aspirin | 69 (9.45, 2.25–7.19) | Data not collected |
| Multiple products (2 or more of aspirin, acetaminophen, NSAIDs) | 127 (26.87, 22.56–31.18) | Data not collected |
| OTC herbal products | 10 (1.37, 1.59–2.23) | Data not collected |
Abbreviation: SNRI, serotonin and norepinephrine reuptake inhibitor.
*
Defined as a diagnosis of plantar fasciitis and PF.